INTRODUCTION AND OBJECTIVES:
The technique of renal reconstruction after robotic partial nephrectomy (RPN) is a modifiable factor with a possible impact on ischemia time, postoperative bleeding, renal function, and incidence of pseudoaneurysms after surgery. We sought to evaluate the feasibility of omitting cortical (outer) renorrhaphy in a multi-institutional setting.
METHODS: We analyzed the data of 1,453 patients who underwent RPN, between 2006 and 2018, within the Vattikuti Collective Quality Initiative database that captures the data from 41 surgeons at 14 centers in 9 countries. Patients having surgery for bilateral tumors (n [ 73) were excluded. Cortical renorrhaphy was omitted in 120 patients; 1260 patients underwent both inner (base) layer renorrhaphy and cortical renorrhaphy. The groups were compared in terms of operative time, ischemia time, blood loss, major (Clavien ! 3) complications, surgical margins, hospital stay, change in estimated glomerular filtration rate (eGFR), and need of angioembolization. Inverse probability of treatment weighting (IPTW) was performed to minimize selection bias by adjusting for age, gender, body mass index, tumor size, polar location, nephrometry score, American Society of Anesthesiologists score, comorbidities, access (retroperitoneal/transperitoneal), preoperative renal function, and center code. (Table 1) RESULTS: Operative and postoperative outcomes are summarized in Table 2 CONCLUSIONS: Omission of cortical renorrhaphy didn't significantly improve operative or ischemia time; however, it also had no adverse effect on perioperative outcomes after RPN in a multiinstitutional setting. (CT and/or MRI) and quantitated the preoperative imaging in each patient to provide comprehensive volumetric measurements (Figure 1) . We compared these measurements with surgical outcomes (operative time, estimated blood loss (EBL), units of transfusion required and length of stay (LOS) and complications graded by Clavien-Dindo.
Univariate analysis and multivariable regression analysis were performed to determine independent associations between outcomes and dependent variables.
RESULTS: Measured volumetric components are outlined in . We used 1:1 propensity score matching to adjust for age, gender, tumor size, comorbidities (diabetes, hypertension) and baseline renal function (eGFR). We compared the serial renal function between the two groups. The probabilities of freedom from CKD stage IV (eGFR < 30 ml/min/1.73 m2) and Overall survival (OS) rate were evaluated using the Kaplan-Meier method.
RESULTS: After propensity matching, 85 group A patients were matched with 85 group B patients. The median follow-up duration in the group A and B were 49 (IQR,13-83) and 42 (IQR,11-68) months, respectively. The median pre-eGFRs were 52.4 and 52.6 ml/min/1.73 m2 in each arm (Group A vs. Group B). There were no significant differences in renal function between the two groups, regardless of the entire postoperative period (all P>0.05, Figure A) . The 5-year CKD IV-free survival rates after surgery were not significantly different between the two groups. (Figure B) . The incidence of new onset CKD stage IV were 8.2% (group A) and 7.1% (group B). The probabilities of freedom from CKD IV after PN were 90.4% for group A versus 86.8% for group B (P[0.229). In Cox hazards models for CKD stage IV, group A was not significantly different compared with group B (hazard ratio [HR] ,0.527; 95% CI, 0.183-1.521; P[0.236). Furthermore, The 5-year OS rates were 90.3% for group A versus 96.2% for group B. (P[0.549, Figure C) CONCLUSIONS: Our data suggest that short WIT has no beneficial effect on renal function and survival rate after PN in patients with pre-existing CKD stage III.
